STAAR Surgical (STAA) Stock Forecast, Price & News

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 7 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" STAA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View STAA analyst ratings or view top-rated stocks.

12 brokerages have issued twelve-month price targets for STAAR Surgical's shares. Their STAA share price forecasts range from $40.00 to $88.00. On average, they anticipate the company's stock price to reach $58.50 in the next twelve months. This suggests a possible upside of 48.4% from the stock's current price.
View analysts price targets for STAA or view top-rated stocks among Wall Street analysts.

STAAR Surgical's stock was trading at $48.54 at the beginning of 2023. Since then, STAA stock has decreased by 18.8% and is now trading at $39.41.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our STAA earnings forecast.

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, August, 2nd. The medical instruments supplier reported $0.23 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.04. The medical instruments supplier had revenue of $92.31 million for the quarter, compared to analysts' expectations of $93.04 million. STAAR Surgical had a net margin of 8.14% and a trailing twelve-month return on equity of 8.37%.

ETFs with the largest weight of STAAR Surgical (NASDAQ:STAA) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC) and Pacer US Export Leaders ETF (PEXL).iShares U.S. Medical Devices ETF (IHI).

STAAR Surgical issued an update on its FY 2026 earnings guidance on Thursday, September, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $500.00 million-$550.00 million.

6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

STAAR Surgical's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.07%), Baillie Gifford & Co. (10.57%), State Street Corp (3.62%), Jackson Square Partners LLC (2.83%), Geode Capital Management LLC (2.06%) and Geneva Capital Management LLC (1.97%). Insiders that own company stock include Aimee S Weisner, Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of STAA stock can currently be purchased for approximately $39.41.

STAAR Surgical (NASDAQ:STAA) has a market capitalization of $1.91 billion and generates $284.39 million in revenue each year. The medical instruments supplier earns $38.76 million in net income (profit) each year or $0.50 on an earnings per share basis.

The company employs 882 workers across the globe.

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962.